Trends in statins utilization and expenditures for the U.S. civilian noninstitutionalized population, 2000 and 2005 [electronic resource] / Marie N. Stagnitti.
Imprint
[Rockville, Md.] : Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality, [2008]
Mode of access: Internet from the MEPS AHRQ web site.
Note
Title from title screen (viewed Sept. 12, 2008).
"May 2008."
Bibliography
Includes bibliographical references.
Summary
This Statistical Brief examines trends for 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, commonly know as statins, for the years 2000 and 2005. The data included in this brief are derived from 2000 and 2005 data for the U.S. civilian noninstitutionalized population from the Household Component of the Medical Expenditure Panel Survey (MEPS-HC). The brief compares 2000 and 2005 total expenditures, total number of purchases, and total number of persons purchasing, as well as average total expenditure and average number of purchases of statins for those with one or more statin purchases.
